TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T02591	Human immunodeficiency virus Envelope glycoprotein gp160	B91CQJ	N-(4-Chloro-3-fluorophenyl)-N'-{2-[(2R,6S)-2,6-dimethylpiperidin-1-yl]ethyl}ethanediamide	Investigative	53324414	C17H23ClFN3O2	355.8	C[C@@H]1CCC[C@@H](N1CCNC(=O)C(=O)NC2=CC(=C(C=C2)Cl)F)C	IC50 = 83200 nM	Poor binder
T02591	Human immunodeficiency virus Envelope glycoprotein gp160	BCN67S	(2S)-2-[[(2S)-2-[(4S,9S)-9-[(1R)-1-Amino-2-hydroxyethyl]-4-(hydroxymethyl)-3,6,10-trioxo-1,2,5-triazecan-2-yl]-3-phenylpropanoyl]amino]-N-[(2S,3R)-1-(benzylamino)-3-hydroxy-1-oxobutan-2-yl]-4-methylpentanamide	Investigative	488962	C36H51N7O9	725.8	C[C@H]([C@@H](C(=O)NCC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N3C(=O)[C@@H](NC(=O)CC[C@H](C(=O)N3)[C@H](CO)N)CO)O	IC50 ~ 100000 nM	Poor binder
T02591	Human immunodeficiency virus Envelope glycoprotein gp160	BJ79UN	N'-(9-Azaspiro[3.5]nonan-6-yl)-N-(4-chloro-3-fluoro-phenyl)oxamide	Investigative	46200686	C16H19ClFN3O2	339.79	C1CC2(C1)CC(CCN2)NC(=O)C(=O)NC3=CC(=C(C=C3)Cl)F	IC50 = 86900 nM	Poor binder
T02591	Human immunodeficiency virus Envelope glycoprotein gp160	BZT7A0	5-[[2-Chloroethyl(ethyl)amino]methyl]-3,3-diphenyl-tetrahydrofuran-2-one	Investigative	488950	C21H24ClNO2	357.9	CCN(CCCl)CC1CC(C(=O)O1)(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 100000 nM	Poor binder